# Dietary Citrus Peel Supplementation Enhances Hepatic Energy Metabolism, Muscle 9-HODE Generation and Isoleucine Catabolism in Beef Cattle

**Authors:** Susumu Muroya, Koichi Ojima, Arata Banno, Hirotaka Nagai, Kazumasa Kakibuchi, Takuma Higuchi, Shuji Sakamoto, Kazutsugu Matsukawa

PMC · DOI: 10.3390/metabo16030201 · Metabolites · 2026-03-18

## TL;DR

Adding yuzu peel to beef cattle diets improves liver energy metabolism and beef flavor by altering specific metabolic pathways.

## Contribution

This study identifies specific metabolic changes in beef cattle due to yuzu peel supplementation, including effects on liver and muscle metabolism.

## Key findings

- DYS increased 9-HODE levels in muscle, a precursor to beef flavor.
- DYS enhanced hepatic energy metabolism via citrate cycle and β-oxidation.
- DYS altered isoleucine catabolism and linoleic acid oxidation in muscle.

## Abstract

Background: Citrus components potentially suppress adipogenic differentiation and lipid accumulation, and exhibit anti-inflammatory and antioxidant effects. We hypothesized that the bioactive compounds in Citrus junos Sieb ex Tanaka (yuzu) fruit peel can alter the systemic metabolism and productivity of beef cattle. Methods: Japanese Brown (JBR) steers were fed with a diet supplemented with 2.5% yuzu peel during the last month of the finishing period. To investigate the effect of dietary yuzu supplementation (DYS) on beef and liver metabolism, we explored the metabolomic profiles of longissimus thoracis (LT, loin) muscle at 14 d postmortem using capillary electrophoresis (CE-TOF/MS) and high-performance liquid chromatography time-of-flight mass spectrometry (LC-TOF/MS). Results: The DYS treatment enhanced the beef fat score compared to that recorded in beef in the no-DYS (None) group (p = 0.050); however, the other carcass quality traits were not significantly different between the DYS and None groups. CE-TOF/MS and LC-TOF/MS revealed 242 and 107 annotated peaks, respectively, for the LT muscle. DYS significantly increased 9(S)-hydroxyoctadecadienoic acid (9-HODE, a beef flavor precursor), cyclo(-Leu-Pro), spermidine, asymmetric dimethylarginine, and 7α-hydroxycholesterol levels and reduced 2-ethylhydracrylic acid (2-EHAA), γ-tocopherol, coenzyme Q10 (CoQ10), sphingomyelin(d18:1/16:0), Cys-Gly, Tyr-Arg, and palmitoylcarnitine levels in postmortem LT muscle (p < 0.050). Concomitantly, in the fresh liver, DYS increased acetyl-CoA, 6-phosphogluconic acid, S-methylglutathione, ATP, ribulose 5-phosphate, and ADP levels and suppressed the content of thiamine, Ala-Ala, riboflavin, and ascorbate 2-sulfate (p < 0.050). Conclusion: Collectively, yuzu ingredients activated ATP production in the liver through the elevation of hepatic energy metabolism primarily in the citrate cycle and β-oxidation, and potentially altered muscle metabolism, including linoleic acid oxidation, FAD-mediated electron transport chain, and isoleucine catabolism, as demonstrated in the reduced accumulation of 2-EHAA and CoQ10 in DYS beef. Moreover, DYS likely affects the gut microbiome by enhancing the production of cyclo(-Leu-Pro), an antimicrobial dipeptide.

## Linked entities

- **Chemicals:** 9(S)-hydroxyoctadecadienoic acid (PubChem CID 5312830), cyclo(-Leu-Pro) (PubChem CID 7074739), asymmetric dimethylarginine (PubChem CID 123831), 7α-hydroxycholesterol (PubChem CID 107722), 2-ethylhydracrylic acid (PubChem CID 188979), coenzyme Q10 (PubChem CID 5281915), sphingomyelin(d18:1/16:0) (PubChem CID 9939941), Cys-Gly (PubChem CID 439498), Tyr-Arg (PubChem CID 123804), palmitoylcarnitine (PubChem CID 461), acetyl-CoA (PubChem CID 444493), 6-phosphogluconic acid (PubChem CID 91493), S-methylglutathione (PubChem CID 115260), ATP (PubChem CID 5957), ribulose 5-phosphate (PubChem CID 439184), ADP (PubChem CID 6022), thiamine (PubChem CID 1130), Ala-Ala (PubChem CID 5484352), riboflavin (PubChem CID 1072), ascorbate 2-sulfate (PubChem CID 54675759)

## Full-text entities

- **Genes:** CYP7A1 (cytochrome P450 family 7 subfamily A member 1) [NCBI Gene 1581] {aka CP7A, CYP7, CYPVII}, ALOX15 (arachidonate 15-lipoxygenase) [NCBI Gene 282139] {aka 15-LOX, ALOX12}, ACADSB (acyl-CoA dehydrogenase short/branched chain) [NCBI Gene 504301], PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 281992] {aka PPARalpha}, ELP1 (elongator acetyltransferase complex subunit 1) [NCBI Gene 8518] {aka DYS, FD, IKAP, IKBKAP, IKI3, TOT1}, PPARGC1A (PPARG coactivator 1 alpha) [NCBI Gene 338446] {aka PPARGC-1A}, CSRP3 (cysteine and glycine rich protein 3) [NCBI Gene 8048] {aka CLP, CMD1M, CMH12, CRP3, MLP}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 281993]
- **Diseases:** cancers (MESH:D009369), Liver Metaboilsm (MESH:D017093), inflammation (MESH:D007249), hepatic steatosis (MESH:D005234), Deficiency of SBCAD (MESH:C566487), injury to (MESH:D014947), NAFLD (MESH:D065626), obesity (MESH:D009765), impaired lipid metabolism (MESH:D052439), CVD (MESH:D002318), diabetes (MESH:D003920), hyperglycemic (MESH:D006944)
- **Chemicals:** Isoleucine (MESH:D007532), Ala-Ala (MESH:C002956), folate (MESH:D005492), Cys-Gly (MESH:C028505), thiamine (MESH:D013831), acetonitrile (MESH:C032159), alpha-ketoglutarate (MESH:D007656), GSSG (MESH:D019803), succinic acid (MESH:D019802), Amino acid (MESH:D000596), bile acid (MESH:D001647), leucine (MESH:D007930), tiglyl-CoA (MESH:C033618), glutathione (MESH:D005978), S-methylglutathione (MESH:C017514), Phospholipid (MESH:D010743), 6-PG (MESH:C008884), gamma-hexalactone (MESH:C430364), Glu (MESH:D018698), nobiletin (MESH:C008661), valine (MESH:D014633), histamine (MESH:D006632), steroid (MESH:D013256), FAD (MESH:D005182), Taurine (MESH:D013654), ATP (MESH:D000255), flavones (MESH:D047309), ascorbate 2-S (MESH:C001956), Acylcarnitine (MESH:C116917), aspartate (MESH:D001224), flavonoid (MESH:D005419), pyruvate (MESH:D019289), Acetyl-CoA (MESH:D000105), HMT (MESH:D008709), urea (MESH:D014508), glucose (MESH:D005947), gamma-tocopherol (MESH:D024504), butyrate (MESH:D002087), PALCAR (MESH:D010172), formic acid (MESH:C030544), flavonols (MESH:D044948), water (MESH:D014867), isopropanol (MESH:D019840), limonoids (MESH:D036701), cholesterol (MESH:D002784), linoleic acid (MESH:D019787), riboflavin (MESH:D012256), propionyl-CoA (MESH:C009061), alpha-KG (-), sulfur compounds (MESH:D013457), citrate (MESH:D019343), 2-EHAA (MESH:C007674), dipeptide (MESH:D004151), anthocyanidins (MESH:D000872), fatty acid (MESH:D005227), Hesperidin (MESH:D006569), TCA (MESH:D014233), flavanones (MESH:D044950), 9-HODE (MESH:C024347), cyclo(-Leu-Pro) (MESH:C445694)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Citrus junos (kuzu, species) [taxon 135197], Mus musculus (house mouse, species) [taxon 10090], Citrus unshiu (satsuma mandarin, species) [taxon 55188], Bos taurus (bovine, species) [taxon 9913], gut metagenome (species) [taxon 749906], Homo sapiens (human, species) [taxon 9606], Ovis aries (domestic sheep, species) [taxon 9940]
- **Mutations:** Ala-Ala, Cys-Gly, G6P, Tyr-Arg

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028232/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028232/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028232/full.md

---
Source: https://tomesphere.com/paper/PMC13028232